Buprenorphine
Product Images NDC 67046-995

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 67046-995). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Chemical structure of Buprenorphine, showing its complex fused ring system, hydroxyl groups, methoxy group, and distinct side chains including a cyclopropylmethyl group. The structure also indicates the presence of a hydrochloride (HCl) salt form.*

FDA Label Image

Illustration (Image 02)

An instructional illustration showing the placement of a buprenorphine sublingual film or tablet under the tongue inside an open mouth. The image demonstrates administration technique for buprenorphine.*

FDA Label Image

Buprenorphine Hydrochloride Sublingual Tablets 2 mg 30s Label (Image 03)

Label for Buprenorphine sublingual tablets, 2 mg, package of 30 tablets. The label includes barcodes, a controlled substance statement, lot number TEST, expiration date 09/12/18, and packaging by Contract Pharmacy Services-PA located in Warrington, PA. Storage instructions recommend 20-25°C (68-77°F). Each tablet contains 2.16 mg of buprenorphine HCl, equivalent to 2 mg base. CPS NDC: 67046-994-30.*

FDA Label Image

Buprenorphine Hydrochloride Sublingual Tablets 8 mg 30s Label (Image 04)

Label for Buprenorphine sublingual tablets, 8 mg strength, containing 30 tablets per package. The label includes barcodes, a prescription-only designation, controlled substance information, lot number TEST, pill ID 799 b, and an expiration date of 09/12/18. It is packaged by Contract Pharmacy Services-PA, with storage instructions of 20-25°C (68-77°F). Each tablet contains 8.64 mg of buprenorphine HCl equivalent to 8 mg of base. The NDC is 67046-995-30.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.